Publications

(Displaying in Reverse Chronological Order)

  1. Research
  2. Publications
  3. Publications
2161
Mital A, Lad R, Thakur A, Negi VS and Ramachandran U. Synthesis of novel 2-substituted 1,4-naphthoquinones using Heck reaction in 'green' reaction media ARKIVOC 2006, 2006, 99-106.
2162
Mital A, Negi VS and Ramachandran U. Synthesis and antimycobacterial activities of certain trifluoromethyl- aminoquinoline derivatives ARKIVOC 2006, 2006, 220-227.
2163
Modi S, Jain JP, Domb AJ and Kumar N. Copolymers of pharmaceutical grade lactic acid and sebacic acid: Drug release behavior and biocompatibility European Journal of Pharmaceutics and Biopharmaceutics 2006, 64, 277-286.
2164
Mondal K, Roy I and Gupta M. Affinity-based strategies for protein purification Analytical Chemistry 2006, 78, 3499-3504.
2165
Monks TJ, Xie R, Tikoo K, Lau SS. Ros-Induced Histone Modifications and their Role in Cell Survival and Cell Death Drug metabolism reviews 2006, 38, 755-767.
2166
Nayyar A, Malde A, Coutinho E and Jain R. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of ring-substituted-2/4-quinolinecarbaldehyde derivatives Bioorganic & Medicinal Chemistry 2006, 14, 7302-7310.
2167
Nayyar A, Malde A, Jain R and Coutinho E. 3D-QSAR study of ring-substituted quinoline class of anti-tuberculosis agents Bioorganic & Medicinal Chemistry 2006, 14, 847-856.
2168
Panchagnula R, Bedi S and Yasvanth A. Polymorphism of rifampicin in FDCs: Correlation with in vitro dissolution test Clinical Research and Regulatory Affairs 2006, 23, 53-70.
2169
Panchagnula R, Bedi S and Yasvanth A. Rifampicin dissolution: Polymorphism or crystal defects Clinical Research and Regulatory Affairs 2006, 23, 71-83.
2170
Panchagnula R, Bindra P, Pillai O, Kumar N and Dey CS. Stability of insulin under iontophoretic conditions Die Pharmazie 2006, 61, 1014-1018.
2171
Panchagnula R, Dhanikula RS and Dhanikula AB. An ex vivo characterization of Paclitaxel loaded chitosan films after implantation in mice Current Drug Delivery 2006, 3, 287-297.
2172
Panchagnula R, Gupta A, Kandavilli S and Varma MV. High-throughput evaluation of non-swellable controlled release matrix tablets Drug Development and Industrial Pharmacy 2006, 32, 669-675.
2173
Panchagnula R, Kumar Bajpai A, Agrawal S and Ashokraj Y. Dissolution testing of marketed rifampicin containing fixed dose combination formulations using a new discriminative media: a post marketing retrospective study Die Pharmazie 2006, 61, 851-854.
2174
Panchagnula R, Parmar J, Kaur K, Singh I, Bade SR and Ashokraj Y. Statistical evaluation of physiological variability of rifampicin in fixed dose combinations International Journal of Pharmaceutics 2006, 313, 13-5.
2175
Panchagnula R, Parmar J, Kaur KJ, Singh I and Bhade SR. Plasma pooling to expedite bioequivalence estimation of rifampicin in fixed dose combinations Methods and Findings in Experimental and Clinical Pharmacology 2006, 28, 161-167.
Information: Duration to be uploaded/incorporated on archival site after the completion of process is 12 months.

2627|145|15